Targeting the Axl and mTOR Pathway Synergizes Immunotherapy and Chemotherapy to Butylidenephthalide in a Recurrent GBM

Figure 2

Intracranial procedure combining sodium fluorescein-guided tumor resection and Cerebraca Wafer implantation. (a) Glioma cells (green fluorescence) were visualized using a yellow (560-nm wavelength) light and resected as extensively as possible. (b) The ventricle of the right parietal was sealed with absorbable biomaterials. (c) The suspected residual tumor cavity was covered with CWs. (d) Near view of CW. (e) CW fixed with bioabsorbable hemostatic meshes. (f) Fibrin sealant materials on hemostatic meshes.